TRANSMEDICS GROUP, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.08 USD | +3.17% |
|
+9.41% | +16.66% |
| 04-18 | Transmedics Group Insider Sold Shares Worth $380,480, According to a Recent SEC Filing | MT |
| 04-05 | Transmedics Group Insider Sold Shares Worth $802,084, According to a Recent SEC Filing | MT |
Chart calendar TransMedics Group, Inc.
7c991c93424343991015e4c8b6d259e.njP6U-uoV8GVRyjAxifLf6-ueAwf0kn7EWVSycSqk3Q.pn6fPJL_IJDjNW2B62avFf78LkRQpiKYdywf_7HL2y7obM8ch84Hm8w2ZQ~595420e70ba0413f861d08d8558eba89
Upcoming events on TransMedics Group, Inc.
Past events on TransMedics Group, Inc.
| 2024-03-12 12:40 | Oppenheimer Healthcare MedTech & Services Conference |
| 2024-03-04 09:50 | TD Cowen Health Care Conference |
| 2024-02-26 16:30 | Q4 2023 Earnings Call |
| 2024-02-26 16:05 | Q4 2023 Earnings Release |
| 2024-01-08 18:00 | JPMorgan Healthcare Conference |
| 2023-11-28 14:30 | Piper Sandler Healthcare Conference |
| 2023-11-06 16:30 | Q3 2023 Earnings Call |
| 2023-11-06 16:05 | Q3 2023 Earnings Release |
| 2023-09-11 08:40 | Morgan Stanley Global Healthcare Conference |
| 2023-08-09 17:00 | Canaccord Genuity Growth Conference |
| 2023-08-03 16:30 | Q2 2023 Earnings Call |
| 2023-08-03 16:05 | Q2 2023 Earnings Release |
| 2023-05-24 | Annual General Meeting |
| 2023-05-01 16:30 | Q1 2023 Earnings Call |
| 2023-05-01 16:05 | Q1 2023 Earnings Release |
| 2023-03-13 12:00 | Oppenheimer Healthcare Conference |
| 2023-03-06 09:10 | Cowen Health Care Conference |
| 2023-02-22 16:30 | FY 2022 Earnings Call |
| 2023-02-22 16:09 | FY 2022 Earnings Release |
| 2023-01-11 20:15 | JP Morgan Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 23,6 24,2 -2.34% | 25,6 24,0 6.99% | 30,3 28,3 7.09% | 93,5 86,2 8.45% | 242 228 5.76% | 367 |
|
EBITDA Million USD | Released Forecast Spread | -28,4 -27,7 -2.47% | -24,8 -24,2 -2.48% | -37,6 -34,6 -8.73% | -28,0 -24,0 -16.66% | -20,6 -5,90 -248.31% | 56,7 |
|
EBIT Million USD | Released Forecast Spread | -29,6 -28,6 -3.37% | -26,4 -26,5 0.39% | -39,4 -39,3 -0.35% | -31,4 -33,0 4.8% | -28,7 -24,4 -17.73% | 1,92 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -33,5 -32,7 -2.47% | -28,7 -28,9 0.59% | -44,2 -43,4 -1.68% | -36,2 -39,4 8.1% | -26,7 -31,1 14.1% | 0,74 |
|
Net income Million USD | Released Forecast Spread | -33,5 -32,9 -2.03% | -28,7 -29,1 1.07% | -44,2 -43,5 -1.7% | -36,2 -39,3 7.79% | -25,0 -29,6 15.35% | -1,92 |
|
EPS USD | Released Forecast Spread | -2,36 -3,95 40.23% | -1,16 -1,19 2.89% | -1,60 -1,57 -1.69% | -1,23 -1,35 8.64% | -0,77 -0,90 14.13% | -0,07 |
| Announcement Date | 17/03/20 | 02/03/21 | 23/02/22 | 22/02/23 | 26/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,67 7,53 28.48% | 15,9 9,65 64.56% | 20,5 16,3 26.09% | 25,7 18,9 36.07% | 31,4 23,6 32.92% | 41,6 37,9 9.57% | 52,5 42,4 23.68% | 66,4 49,2 35.08% | 81,2 68,5 18.5% | 83,8 | 88,4 | 94,2 | 101 | 111 |
|
EBITDA Million USD | Released Forecast Spread | -10,9 -10,0 -8.62% | -8,86 -10,0 11.38% | -8,95 -1,00 -795% | -4,65 -7,00 33.53% | -5,49 -4,00 -37.35% | 3,12 -2,30 235.61% | 5,44 1,07 410.37% | 0,77 1,20 -35.83% | 6,21 6,80 -8.71% | 11,1 | 11,8 | 15,2 | 15,9 | |
|
EBIT Million USD | Released Forecast Spread | -11,3 -11,3 -0% | -9,37 -9,86 5.02% | -9,75 -9,05 -7.65% | -5,54 -10,6 47.86% | -6,78 -8,68 21.91% | -2,09 -7,08 70.5% | -0,91 -3,72 75.61% | -1,12 -4,80 76.59% | 2,60 -2,22 217.5% | 1,25 | 0,99 | 1,38 | 3,15 | -1,23 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,7 -11,8 -7.47% | -10,6 -10,6 -0.02% | -11,5 -9,90 -16.13% | -7,41 -11,3 34.32% | -6,70 -9,74 31.19% | -2,63 -8,90 70.51% | -0,98 -4,59 78.63% | -26,9 -6,32 -325.96% | 3,86 -0,83 567.86% | 3,28 | 2,59 | 2,02 | 3,16 | -1,03 |
|
Net income Million USD | Released Forecast Spread | -12,7 -11,8 -7.31% | -10,6 -10,6 -0.08% | -11,5 -9,95 -15.77% | -7,43 -11,3 34.15% | -6,72 -9,76 31.17% | -2,64 -8,90 70.39% | -1,00 -4,59 78.17% | -25,4 -6,32 -302.12% | 4,03 -0,83 588.21% | 2,60 | 3,29 | 2,90 | 4,16 | -1,03 |
|
EPS USD | Released Forecast Spread | -0,46 -0,43 -8.08% | -0,38 -0,37 -2.09% | -0,41 -0,35 -17.43% | -0,25 -0,40 36.96% | -0,21 -0,32 33.85% | -0,08 -0,27 70.86% | -0,03 -0,14 78.72% | -0,78 -0,19 -311.81% | 0,12 -0,04 400% | -0,01 | 0,00 | 0,01 | 0,05 | -0,03 |
| Announcement Date | 23/02/22 | 03/05/22 | 01/08/22 | 03/11/22 | 22/02/23 | 01/05/23 | 03/08/23 | 06/11/23 | 26/02/24 | - | - | - | - | - |
| 2024-04-29 01:00 | PHILIPS NV: Q1 2024 Earnings Release |
| 2024-04-29 06:00 | REVVITY, INC.: Q1 2024 Earnings Release |
| 2024-04-30 06:20 | GE HEALTHCARE TECHNOLOGIES INC.: Q1 2024 Earnings Release |
| 2024-04-30 16:05 | TRANSMEDICS GROUP, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | INMODE LTD.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | BRUKER CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 16:01 | HOLOGIC, INC.: Q2 2024 Earnings Release |
| 2024-05-02 16:05 | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:05 | ILLUMINA, INC.: Q1 2024 Earnings Release |
| 2024-05-06 | QUANTERIX CORPORATION: Q1 2024 Earnings Release (Projected) |
Past sector events for TransMedics Group, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TMDX Stock
- Calendar TransMedics Group, Inc.
